What's been happening

From new centres and equipment to the latest in care, stay on top with what we are doing

Bupa Member Benefits

19 December, 2018

GenesisCare shares a long partnership with Bupa. As a member, you will be part of a program that aims to improve clinical outcomes for patients with cardiovascular disease. It also guarantees no out-of-pocket expenses for services from GenesisCare cardiologists when you're admitted into hospital. Click here for more information about this partnership. Watch the Bupa…

Read More

December 2018

17 December, 2018

World-first clinical trial to help sufferers of debilitating hand disease

A groundbreaking collaborative research project to find better treatment for Dupuytren’s disease, is underway at Lake Macquarie. Dupuytren’s disease is a genetic and disabling condition that can severely affect mobility in the hands. GenesisCare and Hunter Hand Surgery have begun recruiting 30 patients who will take part in the first phase of the DEPART Study…


November 2018

30 November, 2018

New world-class liver cancer treatment launches on the Gold Coast

New world-class liver cancer treatment launches on the Gold Coast GenesisCare has introduced a new, innovative treatment for patients with liver cancers on the Gold Coast, as a first for the region The world-class, cutting edge form of radiotherapy will be used to deliver high doses of treatment, using a highly focused beam, to target…

2 November, 2018

Innovative breast cancer treatment technique now available within Wide Bay for the first time

An innovative treatment technique for suitable left-sided breast cancer patients has officially launched in regional Queensland. The best practice technique called deep inspiration breath hold (DIBH) reduces the effects of radiotherapy on the heart to minimise the risk of long-term side effects. GenesisCare is now providing the service at its new radiation oncology centres co-located…


October 2018

31 October, 2018

Our new UK Clinical Director of Stereotactic Radiotherapy shares his insights into ‘SABR’

James is a consultant oncologist with a special interest in gastro-intestinal and head/neck cancers at the Queen Elizabeth Hospital, Birmingham. He has a particular focus on precision radiotherapy for liver/pancreas tumours and clinical trials. James recently joined GenesisCare as clinical director of stereotactic radiotherapy, and sees patients at GenesisCare Birmingham and GenesisCare Oxford. Here he…